Skip to main content
LGVN
NASDAQ Life Sciences

Longeveron Grants Executive Chairman Significant Equity Awards

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.643
Mkt Cap
$20.317M
52W Low
$0.475
52W High
$1.8
52W Position info
35% above low
Off High info
64% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

LGVN sits 35% above its 52-week low of $0.475 on light trading volume (0.2× avg).

Summary

Longeveron granted its Executive Chairman equity awards worth approximately $643,000, representing over 3% of the company's market cap, amidst significant financial and operational challenges.


Key Events · Executive and Board Changes · LGVN

  • Significant Equity Awards Granted

    The Executive Chairman received 600,000 Restricted Stock Units (RSUs) and 400,000 non-qualified stock options, granted on July 6, 2026.

  • High Value Relative to Market Cap

    These awards represent approximately $643,000 in potential value, equivalent to over 3% of the company's current market capitalization.

  • Context of Recent Dilution and Challenges

    The grants follow a period of highly dilutive financing, a major regulatory setback for its lead drug candidate, and ongoing Nasdaq delisting concerns.

  • Vesting Schedule

    The awards will vest quarterly over a three-year period, commencing October 1, 2026.


Analysis · LGVN · Life Sciences

Longeveron has granted its Executive Chairman equity awards totaling 1 million underlying shares (600,000 RSUs and 400,000 stock options), valued at approximately $643,000 based on the current stock price. This represents a significant compensation package, equivalent to over 3% of the company's current market capitalization. The awards are particularly notable given the company's recent regulatory setbacks, ongoing Nasdaq delisting concerns, and highly dilutive financing activities. The grants, made on July 6, 2026, follow the recent shareholder approval of a massive increase in authorized shares, providing the headroom for such awards but also adding to potential future dilution for existing shareholders.

At the time of this filing, LGVN was trading at $0.64 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $20.3M. The 52-week trading range was $0.48 to $1.80. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

LGVN - Latest Insights

LGVN
Jul 08, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.643
Real-time Price: $0.643 info
Change: $0 (0%) info
Market Cap: $20.317M info
LGVN
Jul 06, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.6624
Real-time Price: $0.643 info
Change: -$0.0194 (-3%) info
Market Cap: $20.317M info
LGVN
Jun 09, 2026, 9:20 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.7855
Real-time Price: $0.643 info
Change: -$0.1425 (-18%) info
Market Cap: $20.317M info
LGVN
Jun 05, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.730
Real-time Price: $0.643 info
Change: -$0.087 (-12%) info
Market Cap: $20.317M info
LGVN
May 20, 2026, 4:11 PM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $0.780
Real-time Price: $0.643 info
Change: -$0.137 (-18%) info
Market Cap: $20.317M info
LGVN
May 20, 2026, 4:10 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $0.780
Real-time Price: $0.643 info
Change: -$0.137 (-18%) info
Market Cap: $20.317M info
LGVN
May 13, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.7697
Real-time Price: $0.643 info
Change: -$0.1267 (-16%) info
Market Cap: $20.317M info
LGVN
May 08, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.834
Real-time Price: $0.643 info
Change: -$0.191 (-23%) info
Market Cap: $20.317M info
LGVN
May 08, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $0.7651
Real-time Price: $0.643 info
Change: -$0.1221 (-16%) info
Market Cap: $20.317M info
LGVN
May 05, 2026, 5:42 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.8561
Real-time Price: $0.643 info
Change: -$0.2131 (-25%) info
Market Cap: $20.317M info